SCHEMBL6216865

SCHEMBL6216865

Nc1c(C(=O)O)sc2nc(-c3cccs3)nc(-c3ccsc3)c12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 7/20 0.48
IKBKB O14920 1/20 0.43
ALDH1A1 P00352 8/20 0.43
MAPT P10636 7/20 0.43
LIMK1 P53667 1/20 0.41
KDM4E B2RXH2 4/20 0.41
KMT2A Q03164 9/20 0.41
MEN1 O00255 7/20 0.41
TDP1 Q9NUW8 2/20 0.41
HTT P42858 1/20 0.41
MAPK1 P28482 1/20 0.41
CASP1 P29466 1/20 0.41
BRCA1 P38398 1/20 0.41
CASP7 P55210 1/20 0.41
HBB P68871 1/20 0.41
HSD17B10 Q99714 1/20 0.41
LMNA P02545 2/20 0.41
CRHBP P24387 2/20 0.41
CRHR2 Q13324 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27475608 0.92 IKBKB (0.53) HPGDIKBKBALDH1A1MAPTLIMK1
SCHEMBL27490180 0.89 HPGD (0.59) HPGDIKBKBALDH1A1MAPTLIMK1
SCHEMBL6216287 0.87 HPGD (0.47) HPGDIKBKBALDH1A1MAPTLIMK1
SCHEMBL27551749 0.87 MAPT (0.51) HPGDIKBKBALDH1A1MAPTLIMK1
SCHEMBL27490183 0.86 MAPT (0.42) HPGDALDH1A1MAPTKDM4EKMT2A
SCHEMBL6219206 0.85 ALDH1A1 (0.45) HPGDIKBKBALDH1A1MAPTLIMK1
SCHEMBL6216251 0.85 KDM4E (0.49) HPGDIKBKBALDH1A1MAPTKDM4E
SCHEMBL6219498 0.85 MAPT (0.60) HPGDIKBKBALDH1A1MAPTKDM4E
SCHEMBL5026164 0.84 HPGD (0.50) HPGDIKBKBALDH1A1MAPTLIMK1
SCHEMBL27491585 0.83 HPGD (0.47) HPGDIKBKBALDH1A1MAPTLIMK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1171443-B1 BICYCLIC HETEROAROMATIC COMPOUNDS USEFUL AS LH AGONISTS AKZO NOBEL NV (NL) 2005-07-13 EP disclosed
US-6841553-B2 Bicyclic heteroaromatic compounds useful as LH agonists AKZO NOBEL N.V. (NL) 2005-01-11 US disclosed
CN-1177848-C Bicyclic heteroaromatic compounds useful as LH agonists ��˹��ŵ�� 2004-12-01 CN disclosed
US-20030212081-A1 Bicyclic heteroaromatic compounds useful as LH agonists MERCK SHARP & DOHME B.V. (NL) 2003-11-13 US disclosed
US-6569863-B1 Luteinizing hormone (LH) agonists for controlling fertility AKZO NOBEL NV (NL) 2003-05-27 US disclosed
CN-1349535-A Bicyclic heteroaromatic compounds useful as LH agonists AKZO NOBEL NV (NL) 2002-05-15 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030212081-A1 Bicyclic heteroaromatic compounds useful as LH agonists LHCGR, GNRHR, FSHR HPGD 1313/4885IKBKB 1410/4885ALDH1A1 757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.